Cargando…

The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the deadliest cancers in the world with a five-year survival rate of less than 20%. Nonetheless, selecting an appropriate therapeutic agent to inhibit the development of hepatoma cells is still a challenge. Bufalin, a component of the traditional Chinese medi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Han-yu, Zheng, Hui-min, Xia, Cheng, Li, Xiang, Wang, Gang, Zhao, Tong, Cui, Xiao-nan, Wang, Ruo-yu, Liu, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957335/ https://www.ncbi.nlm.nih.gov/pubmed/35345394 http://dx.doi.org/10.2147/OTT.S333233

Ejemplares similares

Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice
por: Zhang, Zhou-Ji, et al.
Publicado: (2014)

Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells
por: Qiu, Dong-Ze, et al.
Publicado: (2013)

Radiosynthesis and pharmacokinetics of [(18)F]fluoroethyl bufalin in hepatocellular carcinoma-bearing mice
por: Yang, Zhaoshuo, et al.
Publicado: (2017)

Bufalin Suppresses Migration and Invasion of Hepatocellular Carcinoma Cells Elicited by Poly (I:C) Therapy
por: Feng, Yinglu, et al.
Publicado: (2018)

Determination of Endogenous Bufalin in Serum of Patients With Hepatocellular Carcinoma Based on HPLC-MS/MS
por: Han, Mengfei, et al.
Publicado: (2020)

Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma
por: Yu, Zhuo, et al.
Publicado: (2022)

Anticancer Effects of Bufalin on Human Hepatocellular Carcinoma HepG2 Cells: Roles of Apoptosis and Autophagy
por: Miao, Qing, et al.
Publicado: (2013)

Bufalin Induces Glioma Cell Death by Apoptosis or Necroptosis
por: LingHu, Hai Rui, et al.
Publicado: (2020)

Bufalin reverses ABCB1-mediated drug resistance in colorectal cancer
por: Yuan, Ze-Ting, et al.
Publicado: (2017)

MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway
por: Xiang, Ru-Fang, et al.
Publicado: (2017)

A Novel Bufalin Derivative Exhibited Stronger Apoptosis-Inducing Effect than Bufalin in A549 Lung Cancer Cells and Lower Acute Toxicity in Mice
por: Liu, Miao, et al.
Publicado: (2016)

Bufalin Reverses Resistance to Sorafenib by Inhibiting Akt Activation in Hepatocellular Carcinoma: The Role of Endoplasmic Reticulum Stress
por: Zhai, Bo, et al.
Publicado: (2015)

Bufalin suppresses esophageal squamous cell carcinoma progression by activating the PIAS3/STAT3 signaling pathway
por: Ju, Qianqian, et al.
Publicado: (2023)

Enhanced Intestinal Permeability of Bufalin by a Novel Bufalin-Peptide-Dendrimer Inclusion through Caco-2 Cell Monolayer
por: Chan, Chi-on, et al.
Publicado: (2017)

Bufalin sensitizes human bladder carcinoma cells to TRAIL-mediated apoptosis
por: Kang, Kyung-Hwa, et al.
Publicado: (2017)

CD147 reinforces [Ca(2+)](i) oscillations and promotes oncogenic progression in hepatocellular carcinoma
por: Tang, Juan, et al.
Publicado: (2015)

Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway
por: Wang, Haiyong, et al.
Publicado: (2016)

Critical Role of Heat Shock Protein 27 in Bufalin-Induced Apoptosis in Human Osteosarcomas: A Proteomic-Based Research
por: Xie, Xian-biao, et al.
Publicado: (2012)

Anti-Inflammatory and Antinociceptive Activities of Bufalin in Rodents
por: Wen, Lili, et al.
Publicado: (2014)

Synthesis and Biological Evaluation of Novel Bufalin Derivatives
por: Sampath, VishnuPriya, et al.
Publicado: (2022)

Therapeutic Targets of Bufalin on Renal Carcinoma and Mechanisms: Experimental Validation of Network Pharmacology Analysis
por: Zhang, Lei, et al.
Publicado: (2022)

The Mechanism of Bufalin-Induced Apoptosis of K562/A02
por: Xie, Ying, et al.
Publicado: (2019)

Bufalin reverses ABCB1-mediated resistance to docetaxel in breast cancer
por: Zhang, Die, et al.
Publicado: (2023)

Bufalin attenuates triple-negative breast cancer cell stemness by inhibiting the expression of SOX2/OCT4
por: Chen, Fei, et al.
Publicado: (2020)

Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes
por: Yuan, Jiani, et al.
Publicado: (2017)

Bufalin induced apoptosis of bladder carcinoma cells through the inactivation of Na+K+-ATPase
por: Huang, Houbao, et al.
Publicado: (2018)

Research Progress of DUB Enzyme in Hepatocellular Carcinoma
por: Zhao, Jie, et al.
Publicado: (2022)

Bufalin inhibits gastric cancer invasion and metastasis by down-regulating Wnt/ASCL2 expression
por: Wang, Jie, et al.
Publicado: (2018)

Progress of MRI Radiomics in Hepatocellular Carcinoma
por: Gong, Xue-Qin, et al.
Publicado: (2021)

Effects of bufalin on the mTOR/p70S6K pathway and apoptosis in esophageal squamous cell carcinoma in nude mice
por: Liu, Yao, et al.
Publicado: (2017)

Synergistic anticancer effects of bufalin and sorafenib by regulating apoptosis associated proteins
por: Wang, Haiyong, et al.
Publicado: (2018)

High-intensity focused ultrasound enhances the effect of bufalin by inducing apoptosis in pancreatic cancer cells
por: Ning, Zhouyu, et al.
Publicado: (2019)

MiR-181a contributes to bufalin-induced apoptosis in PC-3 prostate cancer cells
por: Zhai, Xiao-feng, et al.
Publicado: (2013)

Bufalin-loaded bovine serum albumin nanoparticles demonstrated improved anti-tumor activity against hepatocellular carcinoma: preparation, characterization, pharmacokinetics and tissue distribution
por: Zhang, Huiqing, et al.
Publicado: (2017)

Bufalin suppresses colorectal cancer cell growth through promoting autophagy in vivo and in vitro
por: Pan, Zhe, et al.
Publicado: (2018)

Bufalin suppresses tumour microenvironment-mediated angiogenesis by inhibiting the STAT3 signalling pathway
por: Fang, Kai, et al.
Publicado: (2021)

Bufalin suppresses hepatocarcinogenesis by targeting β-catenin/TCF signaling via cell cycle-related kinase
por: Yu, Zhuo, et al.
Publicado: (2018)

Bufalin Induces Apoptosis and Improves the Sensitivity of Human Glioma Stem-Like Cells to Temozolamide
por: Liu, Jia, et al.
Publicado: (2019)

Targeting Poly (ADP-Ribose) Polymerase Partially Contributes to Bufalin-Induced Cell Death in Multiple Myeloma Cells
por: Huang, He, et al.
Publicado: (2013)

Dominant Suppression of β1 Integrin by Ectopic CD98-ICD Inhibits Hepatocellular Carcinoma Progression
por: Wu, Bo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5gib4nrhfnu2sove3vlbqvdk6n